Simulations Plus Net Profit Margin 2012-2026 | SLP

Simulations Plus net profit margin from 2012 to 2026. Net profit margin can be defined as net Income as a portion of total sales revenue.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
Simulations Plus Net Profit Margin Historical Data
Date TTM Revenue TTM Net Income Net Margin
2026-05-31 $0.08B $0.01B 11.11%
2026-02-28 $0.08B $-0.06B -78.48%
2025-11-30 $0.08B $-0.06B -83.12%
2025-08-31 $0.08B $-0.07B -83.33%
2025-05-31 $0.08B $-0.06B -78.75%
2025-02-28 $0.08B $0.01B 8.86%
2024-11-30 $0.08B $0.01B 10.67%
2024-08-31 $0.07B $0.01B 14.08%
2024-05-31 $0.07B $0.01B 14.71%
2024-02-29 $0.07B $0.01B 16.92%
2023-11-30 $0.06B $0.01B 17.46%
2023-08-31 $0.06B $0.01B 16.67%
2023-05-31 $0.06B $0.01B 17.86%
2023-02-28 $0.06B $0.01B 18.18%
2022-11-30 $0.05B $0.01B 18.52%
2022-08-31 $0.05B $0.01B 22.22%
2022-05-31 $0.05B $0.01B 21.15%
2022-02-28 $0.05B $0.01B 22.00%
2021-11-30 $0.05B $0.01B 20.83%
2021-08-31 $0.05B $0.01B 19.15%
2021-05-31 $0.05B $0.01B 23.40%
2021-02-28 $0.05B $0.01B 21.74%
2020-11-30 $0.04B $0.01B 20.93%
2020-08-31 $0.04B $0.01B 21.95%
2020-05-31 $0.04B $0.01B 23.08%
2020-02-29 $0.04B $0.01B 24.32%
2019-11-30 $0.04B $0.01B 25.71%
2019-08-31 $0.03B $0.01B 26.47%
2019-05-31 $0.03B $0.01B 24.24%
2019-02-28 $0.03B $0.01B 21.88%
2018-11-30 $0.03B $0.01B 25.81%
2018-08-31 $0.03B $0.01B 26.67%
2018-05-31 $0.03B $0.01B 27.59%
2018-02-28 $0.03B $0.01B 29.63%
2017-11-30 $0.03B $0.01B 23.08%
2017-08-31 $0.02B $0.01B 20.83%
2017-05-31 $0.02B $0.01B 22.73%
2017-02-28 $0.02B $0.01B 23.81%
2016-11-30 $0.02B $0.01B 25.00%
2016-08-31 $0.02B $0.01B 25.00%
2016-05-31 $0.02B $0.00B 20.00%
2016-02-29 $0.02B $0.00B 20.00%
2015-11-30 $0.02B $0.00B 20.00%
2015-08-31 $0.02B $0.00B 21.05%
2015-05-31 $0.02B $0.00B 23.53%
2015-02-28 $0.02B $0.00B 20.00%
2014-11-30 $0.01B $0.00B 23.08%
2014-08-31 $0.01B $0.00B 25.00%
2014-05-31 $0.01B $0.00B 25.00%
2014-02-28 $0.01B $0.00B 27.27%
2013-11-30 $0.01B $0.00B 27.27%
2013-08-31 $0.01B $0.00B 30.00%
2013-05-31 $0.01B $0.00B 30.00%
2013-02-28 $0.01B $0.00B 30.00%
2012-11-30 $0.01B $0.00B 30.00%
2012-08-31 $0.01B $0.00B 30.00%
2012-05-31 $0.01B $0.00B 30.00%
2012-02-29 $0.01B $0.00B 30.00%
2011-11-30 $0.01B $0.00B 30.00%
2011-08-31 $0.01B $0.00B 30.00%
2011-05-31 $0.01B $0.00B 30.00%
2011-02-28 $0.01B $0.00B 30.00%
2010-11-30 $0.01B $0.00B 30.00%
2010-08-31 $0.01B $0.00B 20.00%
2010-05-31 $0.01B $0.00B 20.00%
2010-02-28 $0.01B $0.00B 20.00%
2009-11-30 $0.01B $0.00B 11.11%
2009-08-31 $0.01B $0.00B 11.11%
2009-05-31 $0.01B $0.00B 11.11%
2009-02-28 $0.01B $0.00B 11.11%
2008-11-30 $0.01B $0.00B 22.22%
2008-08-31 $0.01B $0.00B 22.22%
2008-05-31 $0.01B $0.00B 22.22%
2008-02-29 $0.01B $0.00B 22.22%
2007-11-30 $0.01B $0.00B 20.00%
2007-08-31 $0.01B $0.00B 22.22%
2007-05-31 $0.01B $0.00B 22.22%
2007-02-28 $0.01B $0.00B 12.50%
2006-11-30 $0.01B 0 0.00%
2006-08-31 $0.01B 0 0.00%
2006-05-31 $0.01B 0 0.00%
2006-02-28 $0.00B 0 0.00%
2005-11-30 $0.00B 0 0.00%
2005-08-31 $0.00B 0 0.00%
2005-05-31 $0.00B $0.00B 25.00%
2005-02-28 $0.00B $0.00B 25.00%
2004-11-30 $0.00B $0.00B 25.00%
2004-08-31 $0.00B $0.00B 25.00%
2004-05-31 $0.01B $0.00B 40.00%
2004-02-29 $0.01B $0.00B 40.00%
2003-11-30 $0.01B $0.00B 40.00%
2003-08-31 $0.01B $0.00B 40.00%
2003-05-31 $0.00B 0 0.00%
2003-02-28 $0.00B 0 0.00%
2002-11-30 $0.00B 0 0.00%
2002-08-31 $0.00B 0 0.00%
2002-05-31 $0.00B 0 0.00%
2002-02-28 $0.00B 0 0.00%
2001-11-30 $0.00B 0 0.00%
2001-08-31 $0.00B 0 0.00%
2001-05-31 $0.00B 0 0.00%
2001-02-28 $0.00B 0 0.00%
2000-11-30 $0.00B 0 0.00%
2000-08-31 $0.00B 0 0.00%
2000-05-31 $0.00B 0 0.00%
2000-02-29 $0.00B 0 0.00%
1999-11-30 $0.00B 0 0.00%
1999-08-31 $0.00B 0 0.00%
1999-05-31 $0.00B $0.00B -25.00%
1999-02-28 $0.00B $0.00B -25.00%
1998-11-30 $0.00B $0.00B -50.00%
Sector Industry Market Cap Revenue
Computer and Technology Computer Software $0.373B $0.079B
Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab, which are based on its proprietary software technologies.
Stock Name Country Market Cap PE Ratio
Microsoft (MSFT) United States $3710.546B 28.92
Oracle (ORCL) United States $457.361B 24.93
SAP SE (SAP) Germany $264.264B 28.27
Adobe (ADBE) United States $105.938B 14.60
Intuit (INTU) United States $91.006B 18.17
Cadence Design Systems (CDNS) United States $80.608B 47.52
Synopsys (SNPS) United States $75.474B 40.02
Dassault Systemes SA (DASTY) France $32.676B 16.79
SS&C Technologies Holdings (SSNC) United States $19.629B 14.20
PTC (PTC) United States $15.302B 17.72
Manhattan Associates (MANH) United States $12.464B 60.05
Descartes Systems Group (DSGX) Canada $6.753B 39.47
Pegasystems (PEGA) United States $6.142B 31.93
Open Text (OTEX) Canada $5.799B 5.80
CommVault Systems (CVLT) United States $5.653B 54.56
ACI Worldwide (ACIW) United States $5.346B 20.76
Trend Micro (TMICY) Japan $5.066B 22.03
Sapiens (SPNS) Israel $2.433B 31.04
Blackbaud (BLKB) United States $2.138B 15.15
Progress Software (PRGS) United States $1.807B 8.99
PROS Holdings (PRO) United States $1.123B 0.00
Swarmer (SWMR) United States $0.514B 0.00
Rand Worldwide (RWWI) United States $0.407B 0.00
OptimizeRx (OPRX) United States $0.148B 12.69
NetSol Technologies (NTWK) United States $0.048B 27.20
Wetouch Technology (WETH) China $0.017B 1.80
Smith Micro Software (SMSI) United States $0.016B 0.00
Neonode (NEON) Sweden $0.015B 0.00
Global Interactive Technologies (GITS) South Korea $0.008B 0.00
Magic Software Enterprises (MGIC) Israel $0.000B 18.90